Emerging research highlights the critical role of the microbiome in bladder cancer. In the article "Bacteria for Treatment: Microbiome in Bladder Cancer", Min K, Kim HT, Lee EH, Park H, and Ha YS (2022) delve into the fascinating potential of harnessing probiotic bacterial species for therapeutic purposes.
The study reviews how bladder cancer, a significant global health issue, may be influenced by microbial ecosystems. These microorganisms, collectively known as the microbiome, are believed to interact with the bladder’s immune environment. Disruptions in this balance have been linked to tumor development, suggesting that targeting specific bacterial populations could be a promising strategy in cancer therapy.
The research outlines the potential for using probiotics, antibiotics, and even bacterial-based therapies to modulate the microbiome, enhancing bladder cancer treatments. Probiotics of interest include Bifidobacterium infantis, Bifidobacterium longum, Lactococcus lactis, Lactobacillus casei strain Shirota and Lactobacillus rhamnosus strain GG. These approaches might improve patient outcomes by reducing recurrence rates or enhancing immune responses.
PROSPER Cancer CARE Naturopath Carla Wrenn believes that the advancement of microbiome science could bring about a revolutionary change in the treatment of various cancers, such as bladder cancer. By examining and treating an individual's microbiome, a more tailored and accurate form of care can be offered, with minimal risks when overseen by a health practitioner trained in microbiome management.
This study underscores the importance of microbiome research in advancing innovative cancer therapies. You can read more here.
This article is intended to be informational only and represents the opinion of the author. It is not intended to be used as medical advice and does not take the place of advice from a qualified health care practitioner in a clinical setting. Please check with your healthcare practitioner before embarking upon any of the treatments discussed.
Comments